PV Bulletin

Filters should be used during the administration of Parenteral Nutrition for patients in all care settings DSI/2026/011

Administration of parenteral nutrition without a filter has been associated with fatal incidents, including embolism.

Primary source: Filters should be used during the administration of Parenteral Nutrition for patients in all care settings

PV Impact Brief

Urgency: HighConfidence: high

What changed

Healthcare professionals are now required to use integrated or add-on filters when administering parenteral nutrition in all care settings.

Why it matters

Failure to use filters during the administration of parenteral nutrition has been linked to severe adverse incidents, including fatal embolisms, highlighting a critical safety issue in patient care.

Action needed

Update local protocols to ensure parenteral nutrition is administered with filters in compliance with the new requirements.

Relevant for
Regulatory Intelligence LeadMedical Safety Lead
Processes impacted
Signal ManagementCountry Compliance
Owner

Regulatory Intelligence Lead

Review cadence

Review in the next regulatory intelligence cycle.

Evidence and confidence

Confidence: highSource updated: Sep 2, 2026

Full briefing

Practical implication

Update local protocols to ensure parenteral nutrition is administered with filters in compliance with the new requirements.

The MHRA issued a safety alert indicating that all parenteral nutrition solutions must be administered via a filter with a pore size no larger than 1.2μm to prevent adverse incidents, including fatalities.

What changed: Healthcare professionals are now required to use integrated or add-on filters when administering parenteral nutrition in all care settings.

Why it matters: Failure to use filters during the administration of parenteral nutrition has been linked to severe adverse incidents, including fatal embolisms, highlighting a critical safety issue in patient care.

Practical implication: Update local protocols to ensure parenteral nutrition is administered with filters in compliance with the new requirements.

View original source

  • Source: MHRA - Alerts, recalls and safety information: medicines and medical devices
  • Published at source: 2026-09-02T09:59:59.000Z
  • Discovered by monitor: 2026-09-02T22:01:06.529Z

Published from the regulator source ingestion pipeline after PV impact triage.

#Safety Signal#Safety Signals#Source-ingestion#Regulator-monitor#Uk#Gov.uk

Related updates for your role

publicFDA · USA · Updated Sep 4, 2026

FDA Grants Accelerated Approval to Etcamah for Advanced Breast Cancer

Urgency: High

Regulatory teams must prepare for updating labeling to include details on the new indication and required diagnostic methods, along with planning for the confirmatory studies mandated by the FDA.

Signal ManagementLabelingRegulatory Intelligence Lead
SOP Impact2 SOPs
ConfidenceHigh
Relevant for: Regulatory Intelligence Lead
verifiedRegulatory action: Regulators
Read impact briefarrow_forward
publicMHRA · UK · Updated Sep 4, 2026

Change to the definition of regulated activity with children from 1 September 2026

Urgency: High

Organizations must re-evaluate roles related to children's activities and prepare to request Enhanced DBS checks including access to the Children’s Barred List check starting from 1 September 2026.

Country ComplianceRegulatory Intelligence Lead
SOP Impact1 SOPs
ConfidenceHigh
Relevant for: Regulatory Intelligence Lead
verifiedRegulatory action: Regulators
Read impact briefarrow_forward
publicUK Health Security Agency · UK · Updated Sep 7, 2026

Low Flu Vaccination Rates Among Primary School Children

Urgency: High

Parents are reminded to complete and return flu vaccination consent forms promptly as vaccination sessions in schools are set to start this week, aiming for completion by late November.

Signal ManagementPV Quality Lead
SOP Impact1 SOPs
ConfidenceHigh
Relevant for: PV Quality Lead, Medical Safety Lead
verifiedRegulatory action: Regulators
Read impact briefarrow_forward
publicANSM (France) · France · Updated Sep 7, 2026Translated From French

Recall of Gore Viabahn Endoprosthesis with Bioactive Heparin Coating

Urgency: High

Health establishments receiving affected devices must be notified, and protocols established to ensure compliance with the recall.

Signal ManagementQPPV
SOP Impact1 SOPs
ConfidenceHigh
Relevant for: QPPV, Medical Safety Lead
verifiedRegulatory action: Regulators
Read impact briefarrow_forward